Dyne Therapeutics, Inc. Common Stock DYN
$20.31
-16.35%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-09-08 | View → |
| 4 | 4 | 2026-09-08 | View → |
| 4 | 4 | 2026-09-08 | View → |
| 4 | Insider transaction | 2026-08-17 | View → |
| 4 | 4 | 2026-08-17 | View → |
| 4 | 4 | 2026-08-17 | View → |
| 4 | 4 | 2026-08-17 | View → |
| 4 | 4 | 2026-08-17 | View → |
| 8-K | 8-K | 2026-07-29 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 10-Q | 10-Q | 2026-07-29 | View → |
| 424B5 | 424B5 | 2026-07-22 | View → |
| 8-K | 8-K | 2026-07-22 | View → |
| 424B5 | 424B5 | 2026-07-21 | View → |
| 8-K | 8-K | 2026-07-20 | View → |
| 4 | Insider transaction | 2026-07-08 | View → |
| 4 | Insider transaction | 2026-06-30 | View → |
| 4 | 4 | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-06-26 | View → |
| 4 | 4 | 2026-06-24 | View → |
| 4 | 4 | 2026-06-23 | View → |
| 8-K | 8-K | 2026-06-22 | View → |
| 4 | 4 | 2026-06-22 | View → |
| 4 | 4 | 2026-06-17 | View → |
| 4 | 4 | 2026-06-17 | View → |
| 4 | 4 | 2026-06-17 | View → |
| 8-K | 8-K | 2026-06-17 | View → |
| 4 | 4 | 2026-06-09 | View → |
| 4 | 4 | 2026-06-09 | View → |
| 4 | 4 | 2026-06-09 | View → |
| 4 | 4 | 2026-06-09 | View → |
| 4 | 4 | 2026-06-09 | View → |
| 4 | 4 | 2026-06-09 | View → |
| 4 | 4 | 2026-06-09 | View → |
| 8-K | 8-K | 2026-06-08 | View → |
| 4 | 4 | 2026-06-05 | View → |
| 8-K | 8-K | 2026-06-03 | View → |
| 4 | 4 | 2026-05-28 | View → |
| 4 | 4 | 2026-05-22 | View → |
| 4 | 4 | 2026-05-14 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $20.31
- Market Cap
- $3.79 billion
- 52-Week Range
- $9.89 – $27.30
- Average Volume
- 2.32 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.